MXCT
MaxCyte Inc
1.00$
-4.6%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -102.9% | 6.3% | -93.1% | -46.4% | -53.8% | -90.0% | -138.7% | -115.8% | -109.2% | -36.8% | -84.6% | -64.1% | -74.0% | |
| 13.5% | 7.0% | 9.8% | 10.4% | 13.1% | 12.2% | 12.3% | 15.0% | 15.7% | 17.6% | 10.8% | 16.6% | 14.8% | |
| 45.1% | 22.8% | 26.6% | 34.2% | 41.3% | 36.1% | 29.2% | 41.3% | 28.6% | 9.7% | 11.8% | 16.0% | 16.0% | |
| -3.7% | 15.9% | -30.3% | 11.6% | 39.0% | -19.7% | -74.1% | -21.0% | 27.7% | 20.0% | -58.0% | 18.2% | -3.0% | |
| 9.0% | 5.8% | 7.1% | 2.8% | 5.0% | 1.7% | 6.3% | 6.9% | 4.4% | 3.2% | 2.3% | 0.9% | 2.6% | |
| 35.2% | -26.4% | -126.9% | 185.9% | 44.2% | -19.2% | 91.7% | 18.1% | 76.0% | 132.5% | 27.5% | 90.3% | 77.6% | |
| – | 1.7% | – | – | 3.2% | – | – | 1.6% | 2.0% | – | – | -20.3% | – | |
| 0.5% | 3.1% | 6.2% | 6.8% | 2.8% | 4.7% | 3.7% | 1.8% | 0.2% | 1.4% | 0.1% | -19.5% | -4.2% | |
| -67.3% | -17.0% | -213.9% | 146.4% | -6.8% | -104.4% | -43.3% | -95.9% | -33.0% | 97.2% | -57.1% | 6.7% | -0.6% | |
| -111.9% | 0.4% | -100.2% | -49.2% | -58.8% | -91.7% | -145.0% | -122.7% | -113.6% | -40.0% | -86.9% | -65.0% | -76.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.